Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1995-10-30
1998-12-29
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424184, 4241871, 4241881, 4242341, A61K 39108, A61K 3921, A61K 3902
Patent
active
058537384
ABSTRACT:
The present invention is directed to a method of treating individuals infected with HIV or at risk of being infected with HIV. The method comprises the step of administering to an individual infected with HIV or at risk of being infected with HIV, an effective amount of a phosphoaminolipid extract derived from bacteria. The phosphoaminolipid extract exhibits an immunomodulating effect in humans, promoting a stabilization or improvement in immune system function.
REFERENCES:
patent: 4182751 (1980-01-01), Ayme
Olinescu, A; Hristescu, S; Salageanu, A; Manda, G; Neagu, M: In vivo and in vitro affect of Cantastim, an immunomodulatory agent extracted . . . Neoplasma: 38/1:pp. 119-128: 1991.
Negut E, G. Szegli, I Peligrad, C Matache, A. Olinescu, and A. Morx: Immunomodulation Activity of a Pseudomonas Aeruginosa Extract-Cantastim: Arch. Roum. Path. Exp. Microbial: T.44, No. 4 pp. 323-335: 1985.
M. Piatek, Jr. et al., "High Levels of HIV-1 in Plasma During All Stages of Infection Determined by Competitive PCR", Science, 1993, vol. 259, pp. 1749-1754.
David A. Katzenstein, M.D. et al., "The Relation of Virologic and Immunologic Markers to Clinical Outcomes After Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter", The New England Journal of Medicine, 1996, vol. 335, No. 15, pp. 1091-1098.
Louis D. Saravolatz, M.D. et al., "Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter", The New England Journal of Medicine,1996, vol. 335, No. 15, pp. 1099-1106.
Lawrence Corey, M.D. et al., "Therapy for Human Immunodeficiency Virus Infection-What Have We Learned?", The New England Journal of Medicine, 1996, ol. 335, No. 15, pp. 1142-1143.
Sudhir Gupta (edited by), "Immunology of HIV Infection", Plenum Press, 1996, 475-491.
Scott M. Hammer, M.D. et al., "A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter", The New England Journal of Medicine, 1996, vol. 335, No. 15, pp. 1081-1090.
Likhite, V., "Experimental Cancer Immunotherapy: Comparison of Tumor Rejection . . . Carynobacterium parvum", Exp. Cancer Immunother., (1976), 985-989.
Antony, V., et al., "Bacillus Calmette -- Guerin-stimulated Neutrophils Release Chemotaxins for Monocytes in Rabbit Pleural Spaces and in Vitro", J. Clin. Invest., (1985), 76:1514-1521.
Jackson, A., et al., "Inductions of ICAM 1 expression on bladder tumours by BCG immunotherapy", J. Clin. Invest., (1994), 76:1514-1521.
Danforth, J., et al., "Microphage Inflammatory protein-1-alpha expression . . . lipoteichoic acid", Clin. Immunopath., (1995), 74:1, Abstract.
Usami, H., et al., "Antitumour effects of streptococcal lipoteichoic acids on Meth A fribrosarcoma", Br. J. Cancer, (1988), 57:70-73.
Ohshima, Y., et al., "Activation of Mononuclear Immune Cells in Response to Staphylococcal Lipoteichoic Acid", Zbl. Bakt., (1991), 275:374-381.
Keller, R., et al., "Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids", Infect. & Immun., (1992), 60:9:3664-3672.
Kusunoki, T., et al., "Molecules from Staphylococcus aureus that Bind CD14 and Stimulate Innate Immune Responses", J. Exp. Med., (1995), 182:1673-1682.
Olinescu, A., et al., "Normal Immune Functions Consequent to Cantastim Therapy in a Case of Chronic Lymphatic Leukemia T CLLT", Rev IG Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Seb Bacteriol Virusol Parazitol Epidemiol, (1988) 33:3:281-288.
Brauner Edgard
Istrate Nicolae
Muni Gita
Raheman Fazal
DynaGen, Inc.
Nelson Brett
Smith Lynette F.
LandOfFree
Methods for treatment of human immunodeficiency virus infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treatment of human immunodeficiency virus infection , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment of human immunodeficiency virus infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1421815